We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
MetLife
MET
$61B
| $31.9M | 0.14% |
874,737
+48,329
| +6% | +$1.68M |
|
177
HCA Healthcare
HCA
$84.8B
| $31.6M | 0.14% |
325,965
+32,089
| +11% | +$3.34M |
|
178
US Bancorp
USB
$99.6B
| $31.4M | 0.14% |
852,184
+20,604
| +2% | +$734K |
|
179
Constellation Brands
STZ
$22.2B
| $31M | 0.14% |
177,145
-36,247
| -17% | -$6.04M |
|
180
BorgWarner
BWA
$13.2B
| $30.9M | 0.14% |
995,620
+189,735
| +24% | +$5M |
|
181
Eaton
ETN
$157B
| $30.6M | 0.13% |
350,312
+12,868
| +4% | +$1.06M |
|
|
DRE
182
DELISTED
Duke Realty Corp.
DRE
| $30.6M | 0.13% |
865,842
+2,456
| +0.3% | +$83.8K |
|
183
AvalonBay Communities
AVB
$27.1B
| $30.4M | 0.13% |
196,885
+3,168
| +2% | +$501K |
|
184
Southern Company
SO
$110B
| $30.1M | 0.13% |
581,452
-17,732
| -3% | -$986K |
|
185
Deere & Co
DE
$170B
| $30.1M | 0.13% |
191,828
+68,871
| +56% | +$9.98M |
|
|
CADE
186
DELISTED
Cadence Bancorporation
CADE
| $29.9M | 0.13% |
3,376,997
| – | – |
|
187
T. Rowe Price
TROW
$25B
| $29.7M | 0.13% |
240,644
-12,170
| -5% | -$1.39M |
|
188
Simon Property Group
SPG
$74.5B
| $29.5M | 0.13% |
431,434
-130,990
| -23% | -$8.22M |
|
189
Cigna
CI
$76.6B
| $29.5M | 0.13% |
156,997
-3,847
| -2% | -$730K |
|
190
Norfolk Southern
NSC
$78.8B
| $29.2M | 0.13% |
166,303
-880
| -0.5% | -$149K |
|
191
Synopsys
SNPS
$71.5B
| $29.2M | 0.13% |
149,685
-2,547
| -2% | -$420K |
|
192
Dow Inc
DOW
$21.6B
| $29M | 0.13% |
711,822
-5,915
| -0.8% | -$217K |
|
193
Realty Income
O
$61.2B
| $29M | 0.13% |
502,951
-244,393
| -33% | -$13M |
|
194
Welltower
WELL
$178B
| $28.7M | 0.13% |
553,850
-34,982
| -6% | -$1.72M |
|
195
iShares MSCI China ETF
MCHI
$6.04B
| $28.3M | 0.12% |
432,000
+122,000
| +39% | +$7.49M |
|
196
Colgate-Palmolive
CL
$72.6B
| $28.2M | 0.12% |
385,300
+2,334
| +0.6% | +$166K |
|
197
Akamai
AKAM
$16.8B
| $28.2M | 0.12% |
262,899
-90,622
| -26% | -$9.11M |
|
|
SCHW
198
Charles Schwab
SCHW
$177B
| $27.9M | 0.12% |
827,535
+35,107
| +4% | +$1.26M |
|
199
Palo Alto Networks
PANW
$264B
| $27.5M | 0.12% |
718,086
+111,000
| +18% | +$3.91M |
|
200
Intuitive Surgical
ISRG
$121B
| $27.3M | 0.12% |
143,934
-194,337
| -57% | -$34.8M |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.